121 related articles for article (PubMed ID: 28765944)
1. c-Myc promotes tumor proliferation and anti‑apoptosis by repressing p21 in rhabdomyosarcomas.
Zhang J; Song N; Zang D; Yu J; Li J; Di W; Guo R; Zhao W; Wang H
Mol Med Rep; 2017 Oct; 16(4):4089-4094. PubMed ID: 28765944
[TBL] [Abstract][Full Text] [Related]
2. FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21
Milewski D; Pradhan A; Wang X; Cai Y; Le T; Turpin B; Kalinichenko VV; Kalin TV
Oncogene; 2017 Feb; 36(6):850-862. PubMed ID: 27425595
[TBL] [Abstract][Full Text] [Related]
3. Realgar induces apoptosis in the chronic lymphocytic leukemia cell line MEC‑1.
Liu X; Li X; Wang L; Lv X; Chen N; Li P; Lu K; Wang X
Mol Med Rep; 2013 Dec; 8(6):1866-70. PubMed ID: 24141727
[TBL] [Abstract][Full Text] [Related]
4. Ceramide-induced G2 arrest in rhabdomyosarcoma (RMS) cells requires p21Cip1/Waf1 induction and is prevented by MDM2 overexpression.
Phillips DC; Hunt JT; Moneypenny CG; Maclean KH; McKenzie PP; Harris LC; Houghton JA
Cell Death Differ; 2007 Oct; 14(10):1780-91. PubMed ID: 17627285
[TBL] [Abstract][Full Text] [Related]
5. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E2 modulates cell cycle function to promote proliferation in pancreatic cancer cells via regulation of the c-Myc-p21
Du S; Wang H; Cai J; Ren R; Zhang W; Wei W; Shen X
Biochem Cell Biol; 2020 Apr; 98(2):191-202. PubMed ID: 32167787
[TBL] [Abstract][Full Text] [Related]
7. The effect of mitotane on viability, steroidogenesis and gene expression in NCI‑H295R adrenocortical cells.
Lehmann TP; Wrzesiński T; Jagodziński PP
Mol Med Rep; 2013 Mar; 7(3):893-900. PubMed ID: 23254310
[TBL] [Abstract][Full Text] [Related]
8. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
[TBL] [Abstract][Full Text] [Related]
9. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest.
Claassen GF; Hann SR
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9498-503. PubMed ID: 10920185
[TBL] [Abstract][Full Text] [Related]
10. TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.
Zhu B; Zhang M; Byrum SD; Tackett AJ; Davie JK
Int J Cancer; 2014 Aug; 135(4):785-97. PubMed ID: 24470334
[TBL] [Abstract][Full Text] [Related]
11. C‑Myc inhibitor 10058‑F4 increases the efficacy of dexamethasone on acute lymphoblastic leukaemia cells.
Lv M; Wang Y; Wu W; Yang S; Zhu H; Hu B; Chen Y; Shi C; Zhang Y; Mu Q; Ouyang G
Mol Med Rep; 2018 Jul; 18(1):421-428. PubMed ID: 29749488
[TBL] [Abstract][Full Text] [Related]
12. STK31 regulates the proliferation and cell cycle of lung cancer cells via the Wnt/β‑catenin pathway and feedback regulation by c‑myc.
Xiong J; Xing S; Dong Z; Niu L; Xu Q; Liu P; Yang P
Oncol Rep; 2020 Feb; 43(2):395-404. PubMed ID: 31894338
[TBL] [Abstract][Full Text] [Related]
13. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
[TBL] [Abstract][Full Text] [Related]
14. Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control.
Graves TG; Harr MW; Crawford EL; Willey JC
Mol Cancer; 2006 Jan; 5():1. PubMed ID: 16403226
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo.
Raimondi L; Ciarapica R; De Salvo M; Verginelli F; Gueguen M; Martini C; De Sio L; Cortese G; Locatelli M; Dang TP; Carlesso N; Miele L; Stifani S; Limon I; Locatelli F; Rota R
Cell Death Differ; 2012 May; 19(5):871-81. PubMed ID: 22117196
[TBL] [Abstract][Full Text] [Related]
16. β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells.
Xu J; Chen Y; Huo D; Khramtsov A; Khramtsova G; Zhang C; Goss KH; Olopade OI
Mol Carcinog; 2016 May; 55(5):431-9. PubMed ID: 25663530
[TBL] [Abstract][Full Text] [Related]
17. Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.
Taylor AC; Schuster K; McKenzie PP; Harris LC
Mol Cancer; 2006 Nov; 5():53. PubMed ID: 17081294
[TBL] [Abstract][Full Text] [Related]
18. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
[TBL] [Abstract][Full Text] [Related]
19. Myostatin inhibits rhabdomyosarcoma cell proliferation through an Rb-independent pathway.
Langley B; Thomas M; McFarlane C; Gilmour S; Sharma M; Kambadur R
Oncogene; 2004 Jan; 23(2):524-34. PubMed ID: 14724580
[TBL] [Abstract][Full Text] [Related]
20. Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level.
Wang Z; Liu M; Zhu H; Zhang W; He S; Hu C; Quan L; Bai J; Xu N
Int J Oncol; 2010 Nov; 37(5):1315-21. PubMed ID: 20878079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
